skip to main content
Idioma:
Refinado por: Base de dados/Biblioteca: ClinicalKey remover idioma: Norueguês remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Adverse Effects and Safety in Glaucoma Patients: Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD)—A Delphi Consensus Statement
Adverse Effects and Safety in Glaucoma Patients: Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD)—A Delphi Consensus Statement
Material Type:
Artigo 		Adicionar ao Meu Espaço

Adverse Effects and Safety in Glaucoma Patients: Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD)—A Delphi Consensus Statement

Thein, Anna-Sophie ; Hedengran, Anne ; Azuara-Blanco, Augusto ; Arita, Reiko ; Cvenkel, Barbara ; Gazzard, Gus ; Heegaard, Steffen ; de Paiva, Cintia S. ; Petrovski, Goran ; Prokosch-Willing, Verena ; Utheim, Tor P. ; Virgili, Gianni ; Kolko, Miriam

American journal of ophthalmology, 2022-09, Vol.241, p.190-197 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
2
Cobimetinib alone and plus venetoclax with/without atezolizumab in patients with relapsed/refractory multiple myeloma
Cobimetinib alone and plus venetoclax with/without atezolizumab in patients with relapsed/refractory multiple myeloma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cobimetinib alone and plus venetoclax with/without atezolizumab in patients with relapsed/refractory multiple myeloma

Schjesvold, Fredrik Hellem ; Paiva, Bruno ; Ribrag, Vincent ; Rodriguez-Otero, Paula ; San-Miguel, Jesus F ; Robak, Pawel ; Hansson, Markus ; Onishi, Maika ; Hamidi, Habib ; Malhi, Vikram ; Dail, Monique ; Javery, Apurva ; Ku, Grace ; Raab, Marc S

Clinical lymphoma, myeloma and leukemia, 2022 [Periódico revisado por pares]

CIG Media Group, LP

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.